Activation of the sigma receptor 1 modulates AMPA receptor-mediated light-evoked excitatory postsynaptic currents in rat retinal ganglion cells

Neuroscience. 2016 Sep 22:332:53-60. doi: 10.1016/j.neuroscience.2016.06.045. Epub 2016 Jun 30.

Abstract

Sigma receptor (σR), a unique receptor family, is classified into three subtypes: σR1, σR2 and σR3. It was previously shown that σR1 activation induced by 1μM SKF10047 (SKF) suppressed N-methyl-d-aspartate (NMDA) receptor-mediated responses of rat retinal ganglion cells (GCs) and the suppression was mediated by a distinct Ca(2+)-dependent phospholipase C (PLC)-protein kinase C (PKC) pathway. In the present work, using whole-cell patch-clamp techniques in rat retinal slice preparations, we further demonstrate that SKF of higher dosage (50μM) significantly suppressed AMPA receptor (AMPAR)-mediated light-evoked excitatory postsynaptic currents (L-EPSCs) of retinal ON-type GCs (ON GCs), and the effect was reversed by the σR1 antagonist BD1047, suggesting the involvement of σR1. The SKF (50μM) effect was unlikely due to a change in glutamate release from bipolar cells, as suggested by the unaltered paired-pulse ratio (PPR) of AMPAR-mediated EPSCs of ON GCs. SKF (50μM) did not change L-EPSCs of ON GCs when the G protein inhibitor GDP-β-S or the protein kinase G (PKG) inhibitor KT5823 was intracellularly infused. Calcium imaging further revealed that SKF (50μM) did not change intracellular calcium concentration in GCs and persisted to suppress L-EPSCs when intracellular calcium was chelated by BAPTA. The SKF (50μM) effect was intact when protein kinase A (PKA) and phosphatidylinostiol (PI)-PLC signaling pathways were both blocked. We conclude that the SKF (50μM) effect is Ca(2+)-independent, PKG-dependent, but not involving PKA, PI-PLC pathways.

Keywords: AMPA receptor; excitatory postsynaptic current; ganglion cell; neurotransmission; retina; σR1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Carbazoles / pharmacology
  • Cells, Cultured
  • Central Nervous System Agents / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Ethylenediamines / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology*
  • Glutamic Acid / metabolism
  • Light
  • Male
  • Patch-Clamp Techniques
  • Phenazocine / analogs & derivatives
  • Phenazocine / pharmacology
  • Rats, Sprague-Dawley
  • Receptors, AMPA / metabolism*
  • Receptors, sigma / antagonists & inhibitors
  • Receptors, sigma / metabolism*
  • Retinal Ganglion Cells / drug effects
  • Retinal Ganglion Cells / metabolism*
  • Tissue Culture Techniques
  • Vision, Ocular / drug effects
  • Vision, Ocular / physiology*
  • Voltage-Sensitive Dye Imaging

Substances

  • Carbazoles
  • Central Nervous System Agents
  • Enzyme Inhibitors
  • Ethylenediamines
  • Receptors, AMPA
  • Receptors, sigma
  • KT 5823
  • N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin
  • Glutamic Acid
  • SK&F 10047
  • Cyclic GMP-Dependent Protein Kinases
  • Phenazocine
  • Calcium